162 related articles for article (PubMed ID: 19852699)
1. Incidence and economic burden of suspected adverse events and adverse event monitoring during AF therapy.
Kim MH; Lin J; Hussein M; Battleman D
Curr Med Res Opin; 2009 Dec; 25(12):3037-47. PubMed ID: 19852699
[TBL] [Abstract][Full Text] [Related]
2. Retrospective study of total healthcare costs associated with chronic nonvalvular atrial fibrillation and the occurrence of a first transient ischemic attack, stroke or major bleed.
Boccuzzi SJ; Martin J; Stephenson J; Kreilick C; Fernandes J; Beaulieu J; Hauch O; Kim J
Curr Med Res Opin; 2009 Dec; 25(12):2853-64. PubMed ID: 19916729
[TBL] [Abstract][Full Text] [Related]
3. Patterns and predictors of discontinuation of rhythm-control drug therapy in patients with newly diagnosed atrial fibrillation.
Kim MH; Klingman D; Lin J; Battleman DS
Pharmacotherapy; 2009 Dec; 29(12):1417-26. PubMed ID: 19947801
[TBL] [Abstract][Full Text] [Related]
4. Cost of atrial fibrillation in United States managed care organizations.
Kim MH; Lin J; Hussein M; Kreilick C; Battleman D
Adv Ther; 2009 Sep; 26(9):847-57. PubMed ID: 19768638
[TBL] [Abstract][Full Text] [Related]
5. Rhythm versus rate control in the contemporary management of atrial fibrillation in-hospital.
Allen Lapointe NM; Sun JL; Kaplan S; d'Almada P; Al-Khatib SM
Am J Cardiol; 2008 Apr; 101(8):1134-41. PubMed ID: 18394447
[TBL] [Abstract][Full Text] [Related]
6. One-year treatment persistence and potential adverse events among patients with atrial fibrillation treated with amiodarone or sotalol: a retrospective claims database analysis.
Kim MH; Smith PJ; Jhaveri M; Lin J; Klingman D
Clin Ther; 2011 Nov; 33(11):1668-1681.e1. PubMed ID: 22108302
[TBL] [Abstract][Full Text] [Related]
7. National assessment of Medicare prescription plan coverage gaps among patients with atrial fibrillation in the US.
Kim MH; Lin J; Kreilick C
Adv Ther; 2009 Aug; 26(8):784-94. PubMed ID: 19690820
[TBL] [Abstract][Full Text] [Related]
8. Estimation of total incremental health care costs in patients with atrial fibrillation in the United States.
Kim MH; Johnston SS; Chu BC; Dalal MR; Schulman KL
Circ Cardiovasc Qual Outcomes; 2011 May; 4(3):313-20. PubMed ID: 21540439
[TBL] [Abstract][Full Text] [Related]
9. Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study.
Sherman DG; Kim SG; Boop BS; Corley SD; Dimarco JP; Hart RG; Haywood LJ; Hoyte K; Kaufman ES; Kim MH; Nasco E; Waldo AL;
Arch Intern Med; 2005 May; 165(10):1185-91. PubMed ID: 15911734
[TBL] [Abstract][Full Text] [Related]
10. Management of atrial fibrillation in the elderly.
Aronow WS
Minerva Med; 2009 Feb; 100(1):3-24. PubMed ID: 19182738
[TBL] [Abstract][Full Text] [Related]
11. Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis.
de Denus S; Sanoski CA; Carlsson J; Opolski G; Spinler SA
Arch Intern Med; 2005 Feb; 165(3):258-62. PubMed ID: 15710787
[TBL] [Abstract][Full Text] [Related]
12. Atrial fibrillation: rate control often better than rhythm control.
Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
[TBL] [Abstract][Full Text] [Related]
13. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
DiMarco JP; Flaker G; Waldo AL; Corley SD; Greene HL; Safford RE; Rosenfeld LE; Mitrani G; Nemeth M;
Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748
[TBL] [Abstract][Full Text] [Related]
14. Retrospective investigation of hospitalized patients with atrial fibrillation in mainland China.
Society of Cardiology, Chinese Medical Association
Chin Med J (Engl); 2004 Dec; 117(12):1763-7. PubMed ID: 15603701
[TBL] [Abstract][Full Text] [Related]
15. Baseline characteristics of patients from Poland enrolled in the global registry of patients with recently diagnosed atrial fibrillation (RecordAF).
Opolski G; Kosior DA; Kurzelewski M; Skrzyńska M; Zagórski A; Janion M; Muzolf M; Wlazłowski R; Pankiewicz B; Łoboz-Grudzień K; Breithardt G;
Kardiol Pol; 2010 May; 68(5):546-54. PubMed ID: 20491018
[TBL] [Abstract][Full Text] [Related]
16. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).
Shelton RJ; Clark AL; Goode K; Rigby AS; Houghton T; Kaye GC; Cleland JG
Heart; 2009 Jun; 95(11):924-30. PubMed ID: 19282313
[TBL] [Abstract][Full Text] [Related]
17. Clinical factors associated with abandonment of a rate-control or a rhythm-control strategy for the management of atrial fibrillation in the AFFIRM study.
Curtis AB; Seals AA; Safford RE; Slater W; Tullo NG; Vidaillet H; Wilber DJ; Slee A
Am Heart J; 2005 Feb; 149(2):304-8. PubMed ID: 15846269
[TBL] [Abstract][Full Text] [Related]
18. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
Flaker GC; Belew K; Beckman K; Vidaillet H; Kron J; Safford R; Mickel M; Barrell P;
Am Heart J; 2005 Apr; 149(4):657-63. PubMed ID: 15990749
[TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation requiring urgent medical care. Approach and outcome in the various departments of admission. Data from the atrial Fibrillation/flutter Italian REgistry (FIRE).
Santini M; De Ferrari GM; Pandozi C; Alboni P; Capucci A; Disertori M; Gaita F; Lombardi F; Maggioni AP; Mugelli A; Salerno-Uriarte JA; Sermasi S; Schwartz PJ;
Ital Heart J; 2004 Mar; 5(3):205-13. PubMed ID: 15119503
[TBL] [Abstract][Full Text] [Related]
20. Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy.
Chung MK; Shemanski L; Sherman DG; Greene HL; Hogan DB; Kellen JC; Kim SG; Martin LW; Rosenberg Y; Wyse DG;
J Am Coll Cardiol; 2005 Nov; 46(10):1891-9. PubMed ID: 16286177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
